- Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone2011 | First Faculty of Medicine
- Pegvisomant - genetically modifieft molecule of growth hormone. Father possibility of the treatment of resistant acromegaly2005 | First Faculty of Medicine
- Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone2011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues2017 | First Faculty of Medicine
- Current and future therapy of acromegaly2016 | First Faculty of Medicine
- Contemporary options and perspectives in the treatment of acromegaly2014 | First Faculty of Medicine
- Possibilities of medical treatment in acromegaly +12005 | Faculty of Medicine in Hradec Králové
- Possibilities of medical treatment in acromegaly2005 | First Faculty of Medicine
- Hypothalamic and pituitary hormones2009 | First Faculty of Medicine
- Acromegaly2010 | First Faculty of Medicine
- Acromegaly and diabetes mellitus2016 | First Faculty of Medicine
- 6.6 Hypotalamické a hypofyzární hormony2018 | First Faculty of Medicine